Patent 9145588 was granted and assigned to Merus Biopharmaceuticals B.V. on September, 2015 by the United States Patent and Trademark Office.
Provided are methods for efficiently and comprehensively screening antibody repertoires from B cells to obtain and produce molecules with binding characteristics and functional activities for use in human therapy.